Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SIBP MMR Vaccine
- Development stage
- Phase 3
- Lead developer
- Shanghai Institute of Biological Products
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Subcutaneous
01
Overview
The SIBP MMR vaccine is a live attenuated combination vaccine developed by the Shanghai Institute of Biological Products (a subsidiary of Sinopharm) to provide immunity against measles, mumps, and rubella. It is a leading MMR vaccine in China, utilizing specific viral strains such as the S79 mumps strain. The vaccine is typically administered as a single dose and is currently undergoing Phase III clinical evaluation in international markets, such as Africa, to demonstrate non-inferiority to WHO-prequalified vaccines like GSK's Priorix in terms of safety and immunogenicity. It has been used domestically in China for many years and is produced in a freeze-dried (lyophilized) powder form for reconstitution.
- Other names
- Measles, Mumps and Rubella Combined Vaccine (Live)SIBP MMRShanghai Institute of Biological Products MMR Vaccine
Beyond the preview
Go deeper on SIBP MMR Vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SIBP MMR Vaccine.